Seers
| Market cap | ₩1.0T |
| PE ratio | 23.87 |
| Forward PE | 18.75 |
| PB ratio | 14.65 |
| EPS | ₩1,102 |
| Dividend (yield) | – |
| Analysts (1–5) | 4.00 · Buy |
| Price target | ₩40,400 (+53.61%) |
| Volume | 549,158 |
| Trading value | ₩14.6B |
| Day’s range | ₩26,050 – ₩27,500 |
| 52-week range | ₩19,820 – ₩64,235 |
| Foreign ownership KR | 4.21% |
| Foreign net buy (Oct 26) KR | −29,132 sh |
| Book value / share | ₩1,795 |
| Founded | 2009 |
Close (KRW) Foreign ownership, % of shares (right axis)
Foreign, institutional and retail net buying KR data
Shares by trading day; positive means net buying. Korea publishes investor-type flows for every stock — global sites such as Yahoo or StockAnalysis do not show them.
| Date | Close | Foreigners | Institutions | Retail | Foreign ownership |
|---|---|---|---|---|---|
| Oct 26 | ₩27,850 | −29,132 | +293,222 | −232,644 | 4.21% |
| Oct 23 | ₩23,700 | +14,561 | +18,431 | −29,038 | 4.00% |
| Oct 22 | ₩23,000 | −163,333 | +198,798 | −30,879 | 3.95% |
| Oct 21 | ₩23,000 | +8,073 | −10,967 | +6,234 | 4.36% |
| Oct 20 | ₩22,800 | +5,799 | +4,048 | −7,221 | 4.46% |
Financials
Annual, consolidated where available, KRW. Columns ending in E are analyst consensus estimates. Source: company filings (DART) via Naver Finance.
| Item | FY2023 | FY2024 | FY2025 | FY2026E |
|---|---|---|---|---|
| Revenue | ₩1.9B | ₩8.1B | ₩48.2B | ₩128.7B |
| Operating income | −₩9.8B | −₩8.7B | ₩16.3B | ₩56.1B |
| Net income | −₩9.9B | −₩8.9B | ₩16.0B | ₩53.6B |
| Operating margin | −520.07% | −107.18% | 33.89% | 43.59% |
| Return on equity | −75.94% | −60.13% | 52.78% | 77.65% |
| Debt-to-equity | 111.47% | 31.24% | 36.81% | – |
| EPS | −₩302 | −₩251 | ₩425 | ₩1,403 |
| Dividend per share | – | – | – | – |
Peers
| Lunit 328130 | ₩14,650 | −0.27% |
| Infinitt Healthcare 071200 | ₩10,460 | −1.60% |
| Sky Labs 386380 | ₩11,010 | +3.09% |
| 3billion 394800 | ₩5,580 | −1.24% |
| GC MediAI 032620 | ₩2,870 | −1.37% |
| Solborn 035610 | ₩4,780 | +0.84% |
About
Seers is an IoMT platform company that uses biosignal analysis AI and wearable devices to provide mobiCARE, an ECG service, and thynC, an inpatient monitoring system, to institutions in Korea and abroad. mobiCARE, a subscription arrhythmia screening service, launched in 2020 and thynC in 2024. Founded in 2009, it listed on the KOSDAQ in 2024.
Seers Co., Ltd. is listed on the KOSDAQ market of the Korea Exchange under the ticker 458870. Industry: Medical & precision instruments.
Direct KRX access through a global broker, a US-listed ADR where one exists, or a Korea ETF — compared in our guide.
Data: Korea Exchange regular-session closing prices, volume and day’s range via Daum Finance, checked against a Naver Finance snapshot at the close; investor flows, foreign ownership and ratios via Naver Finance; company information from DART (Financial Supervisory Service). Updated after each Korean market close; ratios as of Oct 27, 2026; investor flows as of Oct 26, 2026. Delayed data, not investment advice.